{"id":747,"date":"2026-09-01T16:45:45","date_gmt":"2026-09-01T16:45:45","guid":{"rendered":"https:\/\/nhdbio.com\/resources\/aicar-diabetic-polyneuropathy-2024-mouse-study\/"},"modified":"2026-09-01T16:45:45","modified_gmt":"2026-09-01T16:45:45","slug":"aicar-diabetic-polyneuropathy-2024-mouse-study","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/de\/aicar-diabetic-polyneuropathy-2024-mouse-study\/","title":{"rendered":"AICAR bei diabetischer Polyneuropathie: Was die 2024-Mausstudie ergab"},"content":{"rendered":"

Eine 2024-Studie berichtete \u00fcber die Pr\u00e4vention und Umkehrung von Neuropathiema\u00dfnahmen nach experimenteller AICAR-Exposition in Mausmodellen mit Typ-1- und Typ-2-Diabetes. Die Arbeit ist ein n\u00fctzlicher mechanistischer Beweis, aber kein menschliches Behandlungsergebnis.<\/p>

Beweise auf einen Blick<\/h2>
  • Die Experimente wurden an M\u00e4usen und nicht an Menschen durchgef\u00fchrt.<\/li>
  • Bei M\u00e4usen mit fettreicher Ern\u00e4hrung erh\u00f6hte sich das Verh\u00e4ltnis von Phosphorylierung zu Gesamt-AMPK etwa um das Dreifache und das Verh\u00e4ltnis von LC3-II um etwa das Zweifache.<\/li>
  • Befunde zur Mitochondrienatmung und zur Nervenfunktion traten neben systemischen Auswirkungen auf die Insulinsensitivit\u00e4t, den Glukose- und Lipidstoffwechsel auf.<\/li><\/ul><\/div><\/div>
    \"Mausmodell
    Originale redaktionelle Forschungsillustration. Es handelt sich nicht um eine Studienfigur, ein Patientenbild, ein Produktfoto, ein geliefertes Testergebnis oder eine Darstellung einer Katalogcharge.<\/figcaption><\/figure>

    Studienprotokoll<\/h2>

    Die Autoren ma\u00dfen die Nervenleitung, das sensorische Verhalten, die mitochondriale Atmung und Marker, die mit der mitochondrialen Spaltung und dem Zusammenbau von Autophagosomen verbunden sind. Im Modell mit fettreicher Ern\u00e4hrung fiel die durch ADP stimulierte 3-Atmung auf 120 \u00b1 20 nmol O\u2082\/min, verglichen mit 220 \u00b1 20 bei M\u00e4usen mit Kontrolldi\u00e4t; Der gemeldete HFD+AICAR-Wert betrug 240 \u00b1 30.<\/p>

    Modell<\/strong>Mausmodelle des Typs 1 und des Typs 2-Diabetes<\/span><\/div>
    AMPK-Anzeige<\/strong>Ungef\u00e4hr dreifach h\u00f6heres Phosphorylierung\/Gesamt-AMPK-Verh\u00e4ltnis in HFD+AICAR im Vergleich zu HFD<\/span><\/div>
    LC3-II<\/strong>Etwa das Doppelte<\/span><\/div>
    Zustand 3 Atmung<\/strong>120 \u00b1 20 HFD; 220 \u00b1 20-Steuerung; 240 \u00b1 30 HFD+AICAR nmol O\u2082\/min<\/span><\/div>
    \u00dcbersetzung<\/strong>Pr\u00e4klinisch; Es wurde keine Wirksamkeit bei menschlicher Neuropathie festgestellt<\/span><\/div><\/div><\/div>

    Ergebnisse im Kontext<\/h2>

    In derselben Arbeit wurde die Umkehrung festgestellter Defizite bei M\u00e4usen mit Streptozotocin-Diabetes beschrieben. Dieses Ergebnis ist biologisch interessant, aber eine experimentelle Tierexposition stellt keine menschliche Dosis dar und sollte niemals als solche umformatiert werden.<\/p>

    Der Eingriff ver\u00e4nderte auch die Insulinsensitivit\u00e4t, den Glukosestoffwechsel und den Lipidstoffwechsel. Daher ist es unsicher, jedes Ergebnis als Beweis f\u00fcr einen einzelnen AMPK-Mechanismus zu bezeichnen.<\/p>

    Was die Beweise nicht belegen k\u00f6nnen<\/h2>

    Es wurden keine Teilnehmer, kein klinischer Endpunkt oder kein Datensatz zur menschlichen Sicherheit einbezogen.<\/p>

    Mehrere Signalwege und systemische Effekte schr\u00e4nken die Zuordnung zu einem einzelnen Mechanismus ein.<\/p>

    Das Papier validiert nicht die Identit\u00e4t, Reinheit, den Inhalt oder die Eignung einer Katalogcharge.<\/p>","protected":false},"excerpt":{"rendered":"

    Eine 2024-Studie berichtete \u00fcber die Pr\u00e4vention und Umkehrung von Neuropathiema\u00dfnahmen nach experimenteller AICAR-Exposition in Mausmodellen mit Typ-1- und Typ-2-Diabetes. Die Arbeit ist ein n\u00fctzlicher mechanistischer Beweis, aber kein menschliches Behandlungsergebnis.<\/p>","protected":false},"author":1,"featured_media":731,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"313","pim_article_type":"Published evidence review","pim_evidence_level":"Controlled mouse-model study with biochemical and functional endpoints; no human efficacy trial","pim_reviewer":"Site evidence editorial team","pim_reviewed_date":"2026-09-02","pim_editorial_note":"Source-checked on 2026-09-02. Null results, study size, model\/population limits and relevant conflicts are retained. This is not medical advice, a customer case or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"Primary\/regulatory sources, factual claims, numerical results, limitations and product-evidence boundary checked for batch 3.","pim_creation_method":"The editorial workflow began with linked PubMed primary papers, systematic reviews, PubChem identity records and FDA\/DailyMed regulatory records. Population or model, denominators, endpoints, numerical results, null findings, limitations and conflicts were extracted before drafting. AI-assisted drafting and original image generation were used; the final facts and evidence boundaries were checked against the linked records on 2026-09-02. This is not independent peer review.","pim_sources":"[{\"title\":\"AICAR in experimental diabetic polyneuropathy\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39795939\/\",\"note\":\"Primary 2024 mouse study; PMID 39795939.\"},{\"title\":\"Systematic review of AMPK-dependent and independent AICAr effects\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34064363\/\",\"note\":\"Mechanistic review; PMID 34064363.\"},{\"title\":\"PubChem Acadesine record\",\"url\":\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Acadesine\",\"note\":\"Identity, formula, mass and synonyms; CID 17513.\"}]","footnotes":""},"categories":[19],"tags":[],"class_list":["post-747","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-published-study-cases"],"yoast_head":"\nAICAR in Diabetic Polyneuropathy: What the 2024 Mouse Study Found<\/title>\n<meta name=\"description\" content=\"A 2024 study reported prevention and reversal of neuropathy measures after experimental AICAR exposure in mouse models of type 1 and type 2 diabetes. The w\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/de\/aicar-diabetic-polyneuropathy-2024-mouse-study\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AICAR in Diabetic Polyneuropathy: What the 2024 Mouse Study Found\" \/>\n<meta property=\"og:description\" content=\"A 2024 study reported prevention and reversal of neuropathy measures after experimental AICAR exposure in mouse models of type 1 and type 2 diabetes. The w\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/de\/aicar-diabetic-polyneuropathy-2024-mouse-study\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-01T16:45:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/aicar-mouse-neuropathy-evidence.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aicar-diabetic-polyneuropathy-2024-mouse-study\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aicar-diabetic-polyneuropathy-2024-mouse-study\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"AICAR in Diabetic Polyneuropathy: What the 2024 Mouse Study Found\",\"datePublished\":\"2026-09-01T16:45:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aicar-diabetic-polyneuropathy-2024-mouse-study\\\/\"},\"wordCount\":297,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aicar-diabetic-polyneuropathy-2024-mouse-study\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/aicar-mouse-neuropathy-evidence.webp\",\"articleSection\":[\"Published Study Reviews\"],\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/aicar-diabetic-polyneuropathy-2024-mouse-study\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aicar-diabetic-polyneuropathy-2024-mouse-study\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/aicar-diabetic-polyneuropathy-2024-mouse-study\\\/\",\"name\":\"AICAR in Diabetic Polyneuropathy: What the 2024 Mouse Study Found\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aicar-diabetic-polyneuropathy-2024-mouse-study\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aicar-diabetic-polyneuropathy-2024-mouse-study\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/aicar-mouse-neuropathy-evidence.webp\",\"datePublished\":\"2026-09-01T16:45:45+00:00\",\"description\":\"A 2024 study reported prevention and reversal of neuropathy measures after experimental AICAR exposure in mouse models of type 1 and type 2 diabetes. The w\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aicar-diabetic-polyneuropathy-2024-mouse-study\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/aicar-diabetic-polyneuropathy-2024-mouse-study\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aicar-diabetic-polyneuropathy-2024-mouse-study\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/aicar-mouse-neuropathy-evidence.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/aicar-mouse-neuropathy-evidence.webp\",\"width\":1672,\"height\":941,\"caption\":\"AI-generated illustration: Mouse-model AICAR neuropathy research with peripheral nerve and mitochondrial imagery\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aicar-diabetic-polyneuropathy-2024-mouse-study\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AICAR in Diabetic Polyneuropathy: What the 2024 Mouse Study Found\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/de\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"AICAR bei diabetischer Polyneuropathie: Was die 2024-Mausstudie ergab","description":"Eine 2024-Studie berichtete \u00fcber die Pr\u00e4vention und Umkehrung von Neuropathiema\u00dfnahmen nach experimenteller AICAR-Exposition in Mausmodellen mit Typ-1- und Typ-2-Diabetes. Die w\u2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/de\/aicar-diabetic-polyneuropathy-2024-mouse-study\/","og_locale":"de_DE","og_type":"article","og_title":"AICAR in Diabetic Polyneuropathy: What the 2024 Mouse Study Found","og_description":"A 2024 study reported prevention and reversal of neuropathy measures after experimental AICAR exposure in mouse models of type 1 and type 2 diabetes. The w\u2026","og_url":"https:\/\/nhdbio.com\/de\/aicar-diabetic-polyneuropathy-2024-mouse-study\/","og_site_name":"NHD","article_published_time":"2026-09-01T16:45:45+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/aicar-mouse-neuropathy-evidence.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Verfasst von":"NHD Technical Team","Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/aicar-diabetic-polyneuropathy-2024-mouse-study\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/aicar-diabetic-polyneuropathy-2024-mouse-study\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"AICAR in Diabetic Polyneuropathy: What the 2024 Mouse Study Found","datePublished":"2026-09-01T16:45:45+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/aicar-diabetic-polyneuropathy-2024-mouse-study\/"},"wordCount":297,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/aicar-diabetic-polyneuropathy-2024-mouse-study\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/aicar-mouse-neuropathy-evidence.webp","articleSection":["Published Study Reviews"],"inLanguage":"de","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/aicar-diabetic-polyneuropathy-2024-mouse-study\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/aicar-diabetic-polyneuropathy-2024-mouse-study\/","url":"https:\/\/nhdbio.com\/aicar-diabetic-polyneuropathy-2024-mouse-study\/","name":"AICAR bei diabetischer Polyneuropathie: Was die 2024-Mausstudie ergab","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/aicar-diabetic-polyneuropathy-2024-mouse-study\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/aicar-diabetic-polyneuropathy-2024-mouse-study\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/aicar-mouse-neuropathy-evidence.webp","datePublished":"2026-09-01T16:45:45+00:00","description":"Eine 2024-Studie berichtete \u00fcber die Pr\u00e4vention und Umkehrung von Neuropathiema\u00dfnahmen nach experimenteller AICAR-Exposition in Mausmodellen mit Typ-1- und Typ-2-Diabetes. Die w\u2026","breadcrumb":{"@id":"https:\/\/nhdbio.com\/aicar-diabetic-polyneuropathy-2024-mouse-study\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/aicar-diabetic-polyneuropathy-2024-mouse-study\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/aicar-diabetic-polyneuropathy-2024-mouse-study\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/aicar-mouse-neuropathy-evidence.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/aicar-mouse-neuropathy-evidence.webp","width":1672,"height":941,"caption":"AI-generated illustration: Mouse-model AICAR neuropathy research with peripheral nerve and mitochondrial imagery"},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/aicar-diabetic-polyneuropathy-2024-mouse-study\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"AICAR in Diabetic Polyneuropathy: What the 2024 Mouse Study Found"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Peptidrohstoffe und individuelle Peptidsynthese","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"NHD Technisches Team","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"Das technische Team von NHD verwaltet Katalogdokumentationen und Beweiszusammenfassungen f\u00fcr Forschungszwecke. Rezensierte Artikel verweisen auf von Experten begutachtete Artikel, Studienregister und beh\u00f6rdliche Aufzeichnungen, behalten Nullergebnisse und Studieneinschr\u00e4nkungen bei und unterscheiden ver\u00f6ffentlichte Interventionen von Katalogmaterialien. F\u00fcr die Strukturierung kann AI-unterst\u00fctztes Zeichnen verwendet werden; Quellenverkn\u00fcpfungen und Beweisgrenzen bleiben sichtbar. Bei dieser Arbeit handelt es sich nicht um eine unabh\u00e4ngige Begutachtung oder medizinische Beratung.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/de\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/747","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/comments?post=747"}],"version-history":[{"count":0,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/747\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media\/731"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media?parent=747"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/categories?post=747"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/tags?post=747"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}